Skip to content
  • 7,007 federal solicitations are open right now. How many of them are yours?
  • New solicitations are posted every day. The ones you never saw are the ones you cannot win.
  • Stop checking SAM.gov every morning. Let the contracts that fit your business come to you.
  • Tell Abierto what you sell in one sentence. AI reads every open solicitation for you.
  • Deadlines are short. Hear about a solicitation the day it is posted, not the week it closes.
  • Amendments move deadlines. Watch a solicitation and Abierto tells you when it changes.
  • See which contracts in your field are about to end, and who holds them today.
  • Plans from $39 a month. See your matches before you pay.
See plans
AbiertoGet started
Menu

Award notice

2023 NIAID Omnibus Broad Agency Announcement

HHS-NIH-NIAID-BAA2023-1

National Institutes of Health, National Institutes of Health Niaid. Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology).

130 open like this View on SAM.gov Markdown

Awarded

The Global Alliance for TB Drug Development Inc.

$9,851,406.00 on the award notice, May 9, 2024, contract 75N93024C00008

Get the next one like this from National Institutes of Health by email, the day it is posted.Find my opportunities

This one was awarded in 2024

130 like it are open now in research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology)

All 130 open in research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology)

Description

As published on SAM.gov.

This cost-reimbursement contract award was made under full and open competition. This type of contract was selected because costs cannot be adequately defined at the time of contract award.

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
The Global Alliance for TB Drug Development Inc.
UEI
CA1RNRESAZU6
CAGE
52VM4
Vendor location
New York, NY
Contract
75N93024C00008, definitive contract
Obligated
$2,475,623.00, potential $9,851,406
Actions
5 between May 9, 2024 and August 26, 2026
Competition
Full and Open Competition, 18 offers received
Set-aside reported
No Set Aside Used.
Described as
To Develop a Novel Modulator Targeting Proteostasis for the Treatment of M. Tuberculosis.
Match
award number 75N93024C00008 equals the contract number; same awarding office 75N930 (high confidence)
Record
USAspending award page
Recipient
Anivive Lifesciences Inc.
UEI
HR9KVMTD5467
CAGE
8G6Z6
Vendor location
Long Beach, CA
Contract
75N93024C00009, definitive contract
Obligated
$4,889,710.00, potential $33,273,522
Actions
3 between June 3, 2024 and July 7, 2026
Competition
Full and Open Competition, 7 offers received
Set-aside reported
No Set Aside Used.
Described as
BAA Research Area 001 - Development of Vaccine Candidates for Biodefense and Emerging Infectious Diseases
Match
solicitation number HHSNIHNIAIDBAA20231 equals the FPDS solicitation identifier; same awarding office 75N930 (high confidence)
Record
USAspending award page
Recipient
Ge Medical Systems Information Technologies, Inc.
UEI
G2JTZ3UQV9M3
CAGE
9G8T4
Vendor location
Niskayuna, NY
Contract
75N93024C00051, definitive contract
Obligated
$6,685,998.00, potential $9,673,642
Actions
5 between September 12, 2024 and July 29, 2026
Competition
Full and Open Competition, 10 offers received
Set-aside reported
No Set Aside Used.
Described as
BAA2023-1 Research Area 004: Development of in Vitro Diagnostics for Biodefense, Antimicrobial Resistant Infections (Amr), and Emerging Infectious Diseases
Match
solicitation number HHSNIHNIAIDBAA20231 equals the FPDS solicitation identifier; same awarding office 75N930 (high confidence)
Record
USAspending award page
Recipient
Clear Labs Inc.
UEI
DB92QMA4T9G5
CAGE
8DRN3
Vendor location
San Carlos, CA
Contract
75N93024C00052, definitive contract
Obligated
$2,443,960.78, potential $2,957,000
Actions
2 between August 1, 2024 and July 7, 2026
Competition
Full and Open Competition, 10 offers received
Set-aside reported
No Set Aside Used.
Described as
BAA2023-1 Research Area 004: Development of in Vitro Diagnostics for Biodefense, Antimicrobial Resistant Infections (Amr), and Emerging Infectious Diseases
Match
solicitation number HHSNIHNIAIDBAA20231 equals the FPDS solicitation identifier; same awarding office 75N930 (high confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. May 9, 2024

    Award notice, originally solicitation

    Awarded to THE GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT Inc. New York for $9,851,406. SAM.gov, notice 4a6b5d7d47c34f3c90c2f0f920480ccc

Points of contact